Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schaper

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Cytotechnology|February 24, 2012
Regulation of cell growth by IRF-1 in BHK-21 cellsS Kirchhoff, A Kröger, H Cruz, et al.
The Biochemical Journal|January 22, 2000
Cytoplasmic STAT proteins associate prior to activationS Haan, M Kortylewski, I Behrmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
The inhibitory effect of IL-1 beta on IL-6-induced alpha 2-macroglobulin expression is due to activation of NF-kappa BJ G Bode, R Fischer, D Häussinger, et al.
Diabetes Care|May 20, 1999
Increased intimal-medial thickness in newly detected type 2 diabetes: risk factorsT S Temelkova-Kurktschiev, C Koehler, W Leonhardt, et al.
FEBS Letters|January 12, 1999
Constitutive internalization and association with adaptor protein-2 of the interleukin-6 signal transducer gp130S Thiel, H Dahmen, A Martens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transductionJ Schmitz, H Dahmen, C Grimm, et al.
Journal of Immunological Methods|June 16, 2000
A new peptide-affinity tag for the detection and affinity purification of recombinant proteins with a monoclonal antibodyT Böldicke, F Struck, F Schaper, et al.
The Biochemical Journal|September 22, 1998
Functional domains of interferon regulatory factor I (IRF-1)F Schaper, S Kirchhoff, G Posern, et al.
Diabetologia|July 14, 1998
Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individualsT Temelkova-Kurktschiev, C Koehler, F Schaper, et al.
FEBS Letters|August 3, 2000
Differential inhibition of IL-6-type cytokine-induced STAT activation by PMAL Terstegen, B G Maassen, S Radtke, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Cytotechnology|February 24, 2012
Regulation of cell growth by IRF-1 in BHK-21 cellsS Kirchhoff, A Kröger, H Cruz, et al.
The Biochemical Journal|January 22, 2000
Cytoplasmic STAT proteins associate prior to activationS Haan, M Kortylewski, I Behrmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
The inhibitory effect of IL-1 beta on IL-6-induced alpha 2-macroglobulin expression is due to activation of NF-kappa BJ G Bode, R Fischer, D Häussinger, et al.
Diabetes Care|May 20, 1999
Increased intimal-medial thickness in newly detected type 2 diabetes: risk factorsT S Temelkova-Kurktschiev, C Koehler, W Leonhardt, et al.
FEBS Letters|January 12, 1999
Constitutive internalization and association with adaptor protein-2 of the interleukin-6 signal transducer gp130S Thiel, H Dahmen, A Martens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transductionJ Schmitz, H Dahmen, C Grimm, et al.
Journal of Immunological Methods|June 16, 2000
A new peptide-affinity tag for the detection and affinity purification of recombinant proteins with a monoclonal antibodyT Böldicke, F Struck, F Schaper, et al.
The Biochemical Journal|September 22, 1998
Functional domains of interferon regulatory factor I (IRF-1)F Schaper, S Kirchhoff, G Posern, et al.
Diabetologia|July 14, 1998
Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individualsT Temelkova-Kurktschiev, C Koehler, F Schaper, et al.
FEBS Letters|August 3, 2000
Differential inhibition of IL-6-type cytokine-induced STAT activation by PMAL Terstegen, B G Maassen, S Radtke, et al.
Pageof 6